Correspondence to 'Time to change the primary outcome of lupus trials'

Survival among patients with systemic sclerosis-associated pulmonary arterial hypertension in the Australian scleroderma cohort study.

Internal medicine journal·2026

Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.

Annals of the rheumatic diseases·2026

Early detection, treatment initiation, and long-term health outcomes in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic literature review and expert consensus.

Modern rheumatology·2026

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

The Journal of rheumatology·2026

High disease activity persists in adults with childhood-onset lupus.

Lupus science & medicine·2026

High levels of vascular cell adhesion molecule-1 associate with a 'vasculopathic' phenotype in systemic sclerosis with higher mortality.

Rheumatology (Oxford, England)·2026

Immune reset in rheumatic autoimmune disease: from a tantalising metaphor to a measurable therapeutic state.

Annals of the rheumatic diseases·2026

DNA methylation signatures distinguish gout from asymptomatic hyperuricaemia and converge with genetic risk at immune-metabolic loci.

Annals of the rheumatic diseases·2026

BAFF-APRIL blockade reveals isotype-specific pathogenic autoantibody remodelling in antiphospholipid syndrome.

Annals of the rheumatic diseases·2026

HOXD13 links positional identity to primary cilia-dependent signalling in synovial fibroblasts.

Annals of the rheumatic diseases·2026

Predictive molecular signatures for successful tapering of canakinumab in systemic juvenile idiopathic arthritis.

Annals of the rheumatic diseases·2026

Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.

Annals of the rheumatic diseases·2026

Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice.

Journal of neuro-oncology·2026

Liquid biopsy for early detection and biomarker applications in gynecological cancers: current status and future directions.

Clinica chimica acta; international journal of clinical chemistry·2026

Learning curves in robotic and laparoscopic colorectal surgery: a systematic review.

Journal of robotic surgery·2026

From operating room to pathology report: Delphi consensus on pathological assessment of peritoneal cytology and biopsies in staging laparoscopy for gastric cancer.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026

Urine cell-free RNA for bladder cancer detection and treatment response prediction.

Nature medicine·2026

Drain Fluid Lipase as a Biomarker for Anastomotic Leak After Colorectal Resection and an Extra-Peritoneal Anastomosis With Omission of a Diverting Ileostomy.

ANZ journal of surgery·2026

Related Experiment Videos

Correspondence to 'Time to change the primary outcome of lupus trials'

Related Concept Videos

Survival among patients with systemic sclerosis-associated pulmonary arterial hypertension in the Australian scleroderma cohort study.

Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.

Early detection, treatment initiation, and long-term health outcomes in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic literature review and expert consensus.

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

High disease activity persists in adults with childhood-onset lupus.

High levels of vascular cell adhesion molecule-1 associate with a 'vasculopathic' phenotype in systemic sclerosis with higher mortality.

Immune reset in rheumatic autoimmune disease: from a tantalising metaphor to a measurable therapeutic state.

DNA methylation signatures distinguish gout from asymptomatic hyperuricaemia and converge with genetic risk at immune-metabolic loci.

BAFF-APRIL blockade reveals isotype-specific pathogenic autoantibody remodelling in antiphospholipid syndrome.

HOXD13 links positional identity to primary cilia-dependent signalling in synovial fibroblasts.

Predictive molecular signatures for successful tapering of canakinumab in systemic juvenile idiopathic arthritis.

Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.

Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice.

Liquid biopsy for early detection and biomarker applications in gynecological cancers: current status and future directions.

Learning curves in robotic and laparoscopic colorectal surgery: a systematic review.

From operating room to pathology report: Delphi consensus on pathological assessment of peritoneal cytology and biopsies in staging laparoscopy for gastric cancer.

Urine cell-free RNA for bladder cancer detection and treatment response prediction.

Drain Fluid Lipase as a Biomarker for Anastomotic Leak After Colorectal Resection and an Extra-Peritoneal Anastomosis With Omission of a Diverting Ileostomy.

Related Experiment Videos

Correspondence to 'Time to change the primary outcome of lupus trials'

Related Concept Videos

Related Articles